Skip to main content

CIN85/SH3KBP1 293T Cell Transient Overexpression Lysate, Novus Biologicals

Bio-Techne includes Novus Biologicals | Catalog # H00030011-T01

Catalog #
Availability
Size / Price
Qty
Loading...
H00030011-T01

Key Product Details

Species

Human

Applications

Western Blot

Product Summary for CIN85/SH3KBP1 293T Cell Transient Overexpression Lysate

Quality control test: Transient overexpression cell lysate was tested with Anti-SH3KBP1 antibody by Western Blots. Plasmid: pCMV-SH3KBP1 full-length

Product Specifications

Specificity

CIN85/SH3KBP1 293T Cell Transient Overexpression Lysate(Denatured)

Type

293T Cell Transient Overexpression

Protein State

Denatured

Scientific Data Images for CIN85/SH3KBP1 293T Cell Transient Overexpression Lysate

SH3KBP1 transfected lysate.
Lane 1: SH3KBP1 transfected lysate (73.2 KDa) Lane 2: Non-transfected lysate.

Formulation, Preparation, and Storage

Formulation

1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)

Concentration

mg/ml

Shipping

The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.

Storage

Store at -80C. Avoid freeze-thaw cycles.

Background: CIN85/SH3KBP1

Plasmid: pCMV-SH3KBP1 Full length

Long Name

Cbl-Interacting Protein of 85 KDa

Alternate Names

C-Cbl-Interacting Protein, CD2BP3, GIG10, HSB-1, MIG18, SH3KBP1

Gene Symbol

SH3KBP1

Additional CIN85/SH3KBP1 Products

Product Documents for CIN85/SH3KBP1 293T Cell Transient Overexpression Lysate

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for CIN85/SH3KBP1 293T Cell Transient Overexpression Lysate

This product is produced by and distributed for Abnova, a company based in Taiwan.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Lysates are guaranteed for 6 months from date of receipt.

Loading...
Loading...
Loading...
Loading...